Announcements Trials
Browse Landscape

Phase

Phase NA 4Phase 2 3Phase 1 3Phase 1/2 2Phase 3 1

Status

Completed 2Active not recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Plasma cell 3

Conditions

cyclopia sequence 6Prostatic Neoplasms 6Neoplasm Metastasis 6Breast Neoplasms 6Lung Neoplasms 4Dyspnea 4Recurrence 3Primary Myelofibrosis 3Oropharyngeal Neoplasms 3Multiple Myeloma 3Esophageal Neoplasms 3Carcinoma, Squamous Cell 3Squamous Cell Carcinoma of Head and Neck 2Polycythemia Vera 2Pain 2Kidney Neoplasms 2Head and Neck Neoplasms 2Glioblastoma 2Colorectal Neoplasms 2Carcinoma, Renal Cell 2Carcinoma, Non-Small-Cell Lung 2Uterine Cervical Neoplasms 1Urogenital Neoplasms 1Thrombocythemia, Essential 1Splenomegaly 1Speech 1Sezary Syndrome 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Plexosarcoma 1Pathologic Complete Response 1

Interventions

Dexamethasone 337Bortezomib 187Lenalidomide 186Cyclophosphamide 166Melphalan 124Calcium Dobesilate 108daratumumab 95fludarabine phosphate 69carfilzomib 69pomalidomide 68Peripheral Blood Stem Cell Transplantation 64Filgrastim 56Thalidomide 55Busulfan 53Mycophenolic Acid 52Tacrolimus 45Granulocyte Colony-Stimulating Factor 45ixazomib 43fludarabine 42Whole-Body Irradiation 40Cyclosporine 35Etoposide 33dexamethasone acetate 31Antilymphocyte Serum 31isatuximab 29dexamethasone 21-phosphate 26Prednisone 26elotuzumab 25Biopsy 25auricularum 24

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2 × Multiple Myeloma × Surveys and Questionnaires × Clear all
NCT04497961 2025-09-11

A Study of Health-Related Quality of Life in People With Multiple Myeloma Receiving Daratumumab or Lenalidomide

Memorial Sloan Kettering Cancer Center

Phase 2 Active not recruiting
95 enrolled
Plasma cell

Multiple Myeloma

NCT01793051 2021-11-24

Intervention for Symptom Burden During Maintenance Therapy for Multiple Myeloma

M.D. Anderson Cancer Center

Phase 2 Completed
88 enrolled 6 charts
Plasma cell

cyclopia sequence, Multiple Myeloma, Neoplasms, Plasma Cell

NCT00651937 2020-01-14

Trial of Two Stem Cell Doses To Reduce Transplant Induced Symptom Burden

M.D. Anderson Cancer Center

Phase 2 Completed
80 enrolled 7 charts
Plasma cell

Immunoglobulin Light-chain Amyloidosis, Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡